Study of CM559 in Healthy Subjects

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
This study is a single center, randomized, double-blind, placebo-controlled, single dose, dose escalation Phase I clinical study aimed at evaluating the safety, tolerability, pharmacokinetics, pharmacodynamics, and immunogenicity of CM559 administered intravenously at different doses in healthy male subjects.
Epistemonikos ID: 91ef36f5c191fb73a34c22a154b8855bdb12c33e
First added on: Sep 17, 2025